ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia

ClinicalTrials.gov ID: NCT00060892

Public ClinicalTrials.gov record NCT00060892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Leg Ischemia

Study identification

NCT ID
NCT00060892
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnGes USA, Inc.
Industry
Enrollment
104 participants

Conditions and interventions

Interventions

  • HGF plasmid Genetic

Genetic

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
Apr 30, 2006
Completion
Dec 31, 2006
Last update posted
Jan 10, 2008

2003 – 2007

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211
Central Arkansas Veteran's Healthcare System Little Rock Arkansas 72205
Cedars-Sinai Medical Center Los Angeles California 90048
Falk Cardiovascular Research Center Stanford California 94305
VA Medical Center Surgical Service (112) Washington D.C. District of Columbia 20422
Basptist Hospital Pensacola Florida 32501
University of South Florida College of Medicine Tampa Florida 33606
American Cardiovascular Research Institute Atlanta Georgia 30342
University of Chicago Hospitals Chicago Illinois 60637
The Care Group, LLC Indianapolis Indiana 46290
The Ochsner Heart and Vascular Institute Metairie Louisiana 70002
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407
Dartmouth - Hitchcock Medical Center Lebanon New Hampshire 03756
Diabetes Foot and Ankle Center New York New York 10003
NYPH-NY Weill Cornell Medical Center New York New York 10021
University of Rochester Rochester New York 14642
Pitt County Memorial Hospital Greenville North Carolina 27834
The Lindner Clinical Trial Center Cincinnati Ohio 45219
The Cleveland Clinic Foundation Cleveland Ohio 44195
Jobst Vascular Center Toledo Ohio 43606
Medical College of Ohio Toledo Ohio 43614
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Baylor College of Medicine Houston Texas 77030
Peripheral Vascular Associates San Antonio Texas 78215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00060892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2008 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00060892 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →